Volpara Health Technologies Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.10
Dividend & YieldN/A$ (N/A)
Beta 1.06
Market capitalization 154.99M
Operating cash flow -11.36M
ESG Scores unknown

Company description

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.

Sector: Healthcare - Industry: Health Information Services

Financial Ratios
Quick Ratio2.41
Working Capital-0.69
Return On Equity-0.24
Debt To Equity0.01
Fixed Asset Ratio0.35
Fixed Interest Cover-131.75

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities 2.01M 6.61M 846k 3.79M
Total Cashflows From Investing Activities -9.46M -39.31M -23.11M 13.2M
Net Borrowings -87k -290k 2.22M -536k
Total Cash From Financing Activities 20.69M 55.24M 41.87M -25k
Change To Operating Activities -626k -603k -506k -838k
Issuance Of Stock 21.76M 58.65M 41.25M 511k
Net Income -11.74M -20.37M -17.49M -16.44M
Change In Cash 770k -439k 4.2M 1.8M
Effect Of Exchange Rate 181k 278k -542k -10k
Total Cash From Operating Activities -10.64M -16.64M -14.02M -11.36M
Depreciation 302k 1.71M 2.09M 2.71M
Change To Account Receivables -1.09M -2.96M -1.34M -481k
Other Cashflows From Financing Activities -980k -3.12M -1.6M
Change To Netincome 514k -1.53M 1.38M -2.04M
Capital Expenditures -393k -484k -76k -4k

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development 5.65M 10.9M 14.17M 16.84M
Income Before Tax -11.75M -22.31M -18.95M -16.15M
Net Income -11.74M -20.37M -17.49M -16.44M
Selling General Administrative 11.48M 25.14M 24.82M 26.38M
Gross Profit 4.13M 10.83M 18.05M 23.82M
Ebit -12.28M -24.09M -19.24M -16.76M
Operating Income -12.28M -24.09M -19.24M -16.76M
Interest Expense -59k -74k -146k -144k
Income Tax Expense -12k -1.94M -1.46M 287k
Total Revenue 5M 12.6M 19.75M 26.11M
Cost Of Revenue 872k 1.77M 1.69M 2.29M
Total Other Income ExpenseNet 524k 1.78M 287k 607k
Net Income From Continuing Ops -11.74M -20.37M -17.49M -16.44M
Net Income Applicable To Common Shares -11.74M -20.37M -17.49M -16.44M

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 4.79M 20.7M 21.82M 23.1M
Total Stockholder Equity 14.18M 52.22M 72.8M 57.89M
Other Current Liabilities 2.2M 10.77M 11.43M 15.36M
Total Assets 18.97M 72.92M 94.61M 80.98M
Common Stock 84.13M 140.08M 180.68M 181.5M
Other Current Assets 249k 389k 442k 1.01M
Retained Earnings -72.21M -92.57M -110.06M -126.3M
Treasury Stock 2.26M 4.71M 2.18M 2.69M
Cash 4.11M 3.67M 7.87M 9.68M
Total Current Liabilities 4.64M 15.9M 17.78M 20.91M
Other Stockholder Equity 2.26M 4.71M 2.18M 2.69M
Property, Plant, and Equipment 554k 4.55M 3.41M 2.79M
Total Current Assets 17.12M 40.55M 42.95M 30.43M
Net Tangible Assets 13.83M 25.99M 26.37M 12.9M
Net Receivables 2.08M 7.54M 8.62M 9.47M
Accounts Payable 543k 879k 3.87M 1.28M


Insider Transactions

Here are the insider transactions of stock shares related to Volpara Health Technologies Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Diddams (John Flower)D2022-08-18Former1.2M
Pavlidis (John Dimitrious)Purchase at price 0.28 per share.D2022-06-29Independent Non-Executive Director69.1k
Diddams (John Flower)Purchase at price 0.31 per share.D2022-06-22Independent Non-Executive Director30k
Diddams (John Flower)Purchase at price 0.39 per share.D2022-06-16Independent Non-Executive Director30k
Reid (Paul)Purchase at price 0.41 per share.D2022-06-15Independent Non-Executive Chairman115k
Saini (Monica)Sale at price 0.95 per share.D2021-06-10Director (Non-Executive)100k
Saini (Monica)Exercise at price 0.47 per share.D2021-06-01Director (Non-Executive)180k
Diddams (John Flower)Sale at price 0.99 per share.D2020-11-27Director (Non-Executive)400k
Pavlidis (John Dimitrious)Other at price 0.91 per share.D2020-06-16Director200k
Pavlidis (John Dimitrious)Other at price 0.33 per share.D2020-06-03Director100k
Highnam (Ralph)Other at price 0.85 per share.D2020-05-18Chief Executive Officer23.08k
Diddams (John Flower)Other at price 0.85 per share.D2020-05-18Director (Non-Executive)23.08k
Allen (Roger)Sale at price 1.09 per share.D2019-09-05Director (Non-Executive)2M
Highnam (Ralph)Sale at price 1.09 per share.D2019-09-05Chief Executive Officer2M
Diddams (John Flower)Sale at price 1.09 per share.D2019-09-05Director (Non-Executive)300k
Brady (John Michael)Sale at price 1.09 per share.D2019-09-05Director (Non-Executive)800k
Pavlidis (John Dimitrious)Exercise at price 0.32 per share.D2019-06-28Director100k
Diddams (John Flower)Other at price 1.03 per share.D2019-06-14Director (Non-Executive)16.1k
Swinburne (Lynette Mary)Other at price 0.45 per share.D2018-05-30Director (Independent)19.7k
Highnam (Ralph)Other at price 0.45 per share.D2018-05-30Chief Executive Officer9.85k
Diddams (John Flower)Other at price 0.45 per share.D2018-05-30Director (Non-Executive)19.7k
Diddams (John Flower)D2017-11-20Director (Non-Executive)300k
Diddams (John Flower)Purchase at price 0.28 per share.D2017-06-19Director (Non-Executive)20k
Highnam (Ralph)Exercise at price 0.00 per share.D2017-05-17Chief Executive Officer1.98M
Highnam (Ralph)D2017-04-03Chief Executive Officer563.38k
Swinburne (Lynette Mary)D2017-03-31Director (Independent)42k
Diddams (John Flower)Exercise at price 0.00 per share.D2017-02-28Director (Non-Executive)300k
Diddams (John Flower)Other at price 0.43 per share.D2016-12-21Director (Non-Executive)55.4k
Diddams (John Flower)Exercise at price 0.00 per share.D2016-06-18Director (Non-Executive)720k
Diddams (John Flower)Purchase at price 0.33 per share.D2016-06-03Director (Non-Executive)65k
Diddams (John Flower)Other at price 0.38 per share.D2016-04-29Director (Non-Executive)70k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Volpara Health Technologies Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Volpara Health Technologies Limited

Here is the result of two systematic investment strategies applied to Volpara Health Technologies Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Volpara Health Technologies Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Volpara Health Technologies Limited:

Volpara Health Technologies Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 65.53% on the backtest period.

Performance at glance

Performance

65.53 %

Latent gain

1474.3 $

Invested capital

2249.76 $

Annualized return

15.91 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Volpara Health Technologies Limited

This is the result of two momentum investment strategies applied to Volpara Health Technologies Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Volpara Health Technologies Limited

The following chart shows all the entries opened by the momentum investment system on Volpara Health Technologies Limited:

Volpara Health Technologies Limited momentum entries
  • The first momentum investment strategy would give 68.67% of return on Volpara Health Technologies Limited. That represents 3604.04$ of latent gain with 5248.7$ of employed capital.
  • The second momentum investment strategy would give 66.54% of return on Volpara Health Technologies Limited. That represents 2495.97$ of latent gain with 3751.35$ of employed capital.
Performance at glance (1Q Momentum)

Performance

68.67 %

Latent gain

3604.04 $

Invested capital

5248.7 $

Annualized return

16.11 %
Performance at glance (2Q Momentum)

Performance

66.54 %

Latent gain

2495.97 $

Invested capital

3751.35 $

Annualized return

18.28 %

Momentum equity curve on Volpara Health Technologies Limited

The following chart shows the equity curve of the two momentum strategies applied to Volpara Health Technologies Limited:

Volpara Health Technologies Limited momentum equity

Note: the dividends potentially given by Volpara Health Technologies Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Volpara Health Technologies Limited

The following chart shows the employed capital evolution of the two momentum strategies on Volpara Health Technologies Limited since the beginning:

Volpara Health Technologies Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Volpara Health Technologies Limited

Buy the dip entry openings on Volpara Health Technologies Limited

Volpara Health Technologies Limited

The performance achieved by the robo-advisor on Volpara Health Technologies Limited is 34.16%. That represents 170.59$ of latent gain with 499.33$ of employed capital. The following chart shows Volpara Health Technologies Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Volpara Health Technologies Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

34.16 %

Latent gain

170.59 $

Invested capital

499.33 $

Annualized return

16.11 %

Equity curve of the strategy applied to Volpara Health Technologies Limited

The following chart shows the result of the investment strategy applied to Volpara Health Technologies Limited:

Volpara Health Technologies Limited

Note: the dividends potentially given by Volpara Health Technologies Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Volpara Health Technologies Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Volpara Health Technologies Limited:

Volpara Health Technologies Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Volpara Health Technologies Limited

In this section, I will compare the three previous investment strategies applied to Volpara Health Technologies Limited.

Equity curve comparison on Volpara Health Technologies Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Volpara Health Technologies Limited investment strategy comparison

Employed capital comparison on Volpara Health Technologies Limited

Volpara Health Technologies Limited investment comparison

Performance comparison on Volpara Health Technologies Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 65.53% 1474.3$ 2249.76$ 15.91%
Momentum 1 quarter 68.67% 3604.04$ 5248.7$ 17.7%
Momentum 2 quarters 66.54% 2495.97$ 3751.35$ 18.28%
Non-directional 34.16% 170.59$ 499.33$ 16.11%
Annualized return comparison

Automatic investment

15.91 %

Momentum 1Q

18.28 %

Momentum 2Q

18.28 %

Non-directional

16.11 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Volpara Health Technologies Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Volpara Health Technologies Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Volpara Health Technologies Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Volpara Health Technologies Limited
Country New Zealand
City Wellington
Address Simpl House
Phone 64 4 499 6029
Website www.volparahealth.com
FullTime employees 189
Industry Health Information Services
Sector Healthcare
Exchange XASX
Ticker VHT.XASX
Market www2.asx.com.au

Volpara Health Technologies Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown